Determinants of mRNA Lifetime and Translation Efficiency
Dauer: 48 Monate, Fördersumme: € 799.100
Innate immune reprogramming to overcome therapy resistance in high-risk colorectal cancer
Dauer: 36 Monate, Fördersumme: € 800.000
PHARMACOSCOPY: Breaking resistance of refractory blood cancers through ex vivo automated image-based analysis of drug action
Dauer: 46 Monate, Fördersumme: € 904.000
Prolongation of kidney transplant survival through risk stratification of omics-wide incompatibilities using systems biology - a personalized medicine approach
Dauer: 36 Monate, Fördersumme: € 879.500
Pan-metabolic profiling of Archaea: The ecology of genomics
Dauer: 96 Monate, Fördersumme: € 1.599.600
Network Medicine - An interactome-based approach to rare diseases
Dauer: 96 Monate, Fördersumme: € 1.598.300